These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38131000)

  • 1. Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study.
    Lee GB; Huh Y; Lee SH; Han B; Kim YH; Kim DH; Kim SM; Choi YS; Cho KH; Nam GE
    World J Gastroenterol; 2023 Dec; 29(45):5962-5973. PubMed ID: 38131000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease.
    Xiao P; Liang P; Gao P; Wu J
    Front Endocrinol (Lausanne); 2022; 13():1057261. PubMed ID: 36531457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey.
    Kang S; Moon MK; Kim W; Koo BK
    J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1232-1241. PubMed ID: 32638541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Serum Ferritin Levels and Metabolic-associated Fatty Liver Disease in Adults: a Cross-sectional Study Based on the NHANES.
    Li JH; Ma XY; Yi Y; Li LR; Xu ZY; Chang Y
    Curr Med Sci; 2024 Jun; 44(3):494-502. PubMed ID: 38748368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017-2018.
    Zhang Y; Zhang M; Jiang S; Hu H; Wang X; Yu F; Huang Y; Liang Y
    Cancer Causes Control; 2024 Sep; 35(9):1271-1282. PubMed ID: 38764062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between dietary intake of carotenoids and metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017-March 2020.
    Yu J; Guo P
    Public Health Nutr; 2024 Sep; 27(1):e168. PubMed ID: 39313756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between micronutrients intake and metabolic-associated fatty liver disease: a cross-sectional study based on the National Health and Nutrition Examination Survey.
    Hou JZ; Wu QW; Zhang L
    J Nutr Sci; 2023; 12():e117. PubMed ID: 38033509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease.
    Chun HS; Kim MN; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1168-1178. PubMed ID: 34337887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Serum Iron Status with MAFLD and Liver Fibrosis in the USA: a Nationwide Cross-Section Study.
    Yu G; Liu L; Qin T; Luo Y; Song C; Chen X; Duan H; Jiang Y; Zeng H; Wan H; Shen J
    Biol Trace Elem Res; 2024 Jan; 202(1):87-98. PubMed ID: 37079265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults.
    Zhou T; Ye J; Lin Y; Wang W; Feng S; Zhuo S; Zhong B
    Br J Nutr; 2023 Oct; 130(8):1373-1384. PubMed ID: 36896599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study.
    Xing M; Ni Y; Zhang Y; Zhao X; Yu X
    Front Nutr; 2023; 10():1246157. PubMed ID: 38024359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.
    Zhu C; Ma H; Huang D; Li G; Gao J; Cai M; You H; Bu L; Qu S
    Front Endocrinol (Lausanne); 2022; 13():815995. PubMed ID: 35222274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory diet reduces risk of metabolic dysfunction-associated fatty liver disease among US adults: a nationwide survey.
    Hu W; Luo L; Li M; Xiong X; Huang W; Huang Y; Sun J; Ding H; Yu H
    Scand J Gastroenterol; 2024 Oct; 59(10):1192-1201. PubMed ID: 39215699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease.
    Han E; Lee YH; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Kim SU
    Gut Liver; 2022 Sep; 16(5):786-797. PubMed ID: 35321955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of serum folate and vitamin C levels with metabolic dysfunction-associated fatty liver disease in US adults: A nationwide cross-sectional study.
    Jiang Y; Cao H; Chen X; Yu G; Song C; Duan H; Tian F; Wan H; Shen J
    Front Public Health; 2022; 10():1022928. PubMed ID: 36388270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between metabolic dysfunction-associated fatty liver disease, chronic kidney disease, and abdominal obesity: a national retrospective cohort study.
    Cen C; Fan Z; Ding X; Tu X; Liu Y
    Sci Rep; 2024 Jun; 14(1):12645. PubMed ID: 38825630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Sensitivity to Free Triiodothyronine With MAFLD and Its Progression to Liver Fibrosis in Euthyroid Adults.
    Wan H; Yu G; Xu S; Chen X; Jiang Y; Duan H; Lin X; Ma Q; Wang D; Liang Y; Liu L; Shen J
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e687-e697. PubMed ID: 36999544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A problem of proportions: estimates of metabolic associated fatty liver disease and liver fibrosis in Australian adults in the nationwide 2012 AusDiab Study.
    Farrell AM; Magliano DJ; Shaw JE; Thompson AJ; Croagh C; Ryan MC; Howell J
    Sci Rep; 2022 Feb; 12(1):1956. PubMed ID: 35121749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population.
    Zhang YC; Lyu ZY; Ma B; Li LM; Wang W; Sheng C; Dai HJ; Huang YB; Song FF; Song FJ; Chen KX
    Hepatol Int; 2022 Aug; 16(4):835-845. PubMed ID: 35701716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.